Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LRMRLarimar Therapeutics, Inc.

Nasdaq · CIK 0001374690
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts313

Identity from submissions API

NameLarimar Therapeutics, Inc.
CIK0001374690
TickersLRMR
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN203857670
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone844-511-9056
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ZAFGEN, INC. (2010-03-01T05:00:00.000Z → 2020-05-19T04:00:00.000Z)
  • ZAFGEN INC (2006-08-28T04:00:00.000Z → 2008-11-03T05:00:00.000Z)
Business address
THREE BALA PLAZA EAST. SUITE 506
BALA CYNWYD
PA
19004
PA
Mailing address
THREE BALA PLAZA EAST. SUITE 506
BALA CYNWYD
PA
19004
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

710 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 4 4 0001193125-26-467167 4675
2026-11-16 4 4 0001193125-26-463941 4663
2026-11-16 S-8 S-8 0001193125-26-463459 333-300082 261560640 33 225629 1 1
2026-11-16 10-Q 10-Q 0001193125-26-462242 001-36510 261555700 34 9682762 1 1
2026-11-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000194 005-88225 261555633 34 12757
2026-11-16 8-K 8-K 2.02,9.01 0001193125-26-462054 001-36510 261555387 34 1072721 1 1
2026-11-12 4 4 0001193125-26-459008 6578
2026-11-12 4 4 0001193125-26-458853 11861
2026-11-12 4 4 0001193125-26-458848 4664
2026-11-12 4 4 0001193125-26-458847 5218
2026-11-12 4 4 0001193125-26-458845 5299
2026-11-12 4 4 0001193125-26-458834 5243
2026-11-12 4 4 0001193125-26-458830 4739
2026-11-09 8-K 8-K 2.02,8.01,9.01 0001193125-26-453586 001-36510 261535977 34 17829296 1 1
2026-10-01 4 4 0001193125-26-410719 7424
2026-10-01 3 3 0001193125-26-410715 809301
2026-09-29 8-K 8-K 5.02 0001193125-26-407331 001-36510 261423710 34 156355 1 1
2026-08-04 10-Q 10-Q 0001193125-26-331529 001-36510 261235430 34 8868258 1 1
2026-08-04 8-K 8-K 2.02,8.01,9.01 0001193125-26-331516 001-36510 261235408 34 19306135 1 1
2026-07-08 4 4 0001193125-26-298523 5877
2026-06-29 8-K 8-K 8.01,9.01 0001193125-26-286780 001-36510 261131213 34 12826898 1 1
2026-05-20 4 xslF345X06/e665501_4-larimar.xml 0001193805-26-000669 13356
2026-05-20 4 4 0001193125-26-232933 6082
2026-05-20 4 4 0001193125-26-232705 5592
2026-05-20 4 4 0001193125-26-232667 5600
2026-05-20 4 4 0001193125-26-232657 5603
2026-05-20 4 4 0001193125-26-232644 5564
2026-05-19 8-K 8-K 5.07 0001193125-26-230852 001-36510 26999257 34 179640 1 1
2026-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001140361-26-021322 005-88225 26979378 34 8666
2026-05-14 10-Q 10-Q 0001193125-26-224087 001-36510 26979243 34 7711808 1 1
2026-05-14 8-K 8-K 2.02,8.01,9.01 0001193125-26-222746 001-36510 26975791 34 26072013 1 1
2026-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-053218 005-88225 26927931 34 15581
2026-04-20 ARS ARS 0001193125-26-163954 001-36510 26875122 34 1939778
2026-04-20 DEF 14A DEF 14A 0001193125-26-163942 001-36510 26875080 34 13069511 1 1
2026-04-10 PRE 14A PRE 14A 0001193125-26-151258 001-36510 26854938 34 12260098 1 1
2026-03-19 S-8 S-8 0001193125-26-116159 333-294457 26775080 33 175541 1 1
2026-03-19 10-K 10-K 0001193125-26-115878 001-36510 26774028 34 13162702 1 1
2026-03-19 8-K 8-K 2.02,9.01 0001193125-26-115119 001-36510 26772377 34 1104367 1 1
2026-03-09 8-K 8-K 8.01,9.01 0001193125-26-098493 001-36510 26734987 34 24930777 1 1
2026-03-02 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193805-26-000206 005-88225 26710460 34 28372
2026-03-02 4 xslF345X05/e665206_4-larimar.xml 0001193805-26-000205 37902
2026-03-02 4 4 0001193125-26-085515 5454
2026-03-02 4 4 0001193125-26-085514 4795
2026-03-02 4 4 0001193125-26-085510 4784
2026-02-27 8-K 8-K 1.01,9.01 0001193125-26-077646 001-36510 26690986 34 476937 1 1
2026-02-26 424B5 424B5 0001193125-26-076775 333-279275 26688518 33 1476839
2026-02-25 424B5 424B5 0001193125-26-071493 333-279275 26678425 33 1508547
2026-02-24 8-K 8-K 8.01,9.01 0001193125-26-065186 001-36510 26667429 34 25294503 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-26-000047 005-88225 26642344 34 12861
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-26-005033 005-88225 26626956 34 8397
2026-01-27 4 4 0001193125-26-024833 7283
2026-01-27 4 4 0001193125-26-024832 7221
2026-01-27 4 4 0001193125-26-024826 13592
2026-01-27 4 4 0001193125-26-024824 7229
2026-01-22 8-K 8-K 3.02,5.03,9.01 0001193125-26-018664 001-36510 26549664 34 279147 1 1
2026-01-12 8-K 8-K 2.02,8.01,9.01 0001193125-26-010409 001-36510 26526923 34 25075212 1 1
2025-12-17 8-K 8-K 3.02,5.03,9.01 0001193125-25-321738 001-36510 251577277 34 376248 1 1
2025-11-10 8-K 8-K 8.01,9.01 0001193125-25-273217 001-36510 251464271 34 23881769 1 1
2025-11-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-107757 005-88225 251458559 34 15417
2025-11-05 10-Q 10-Q 0001193125-25-266969 001-36510 251454213 34 8501605 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001193125-25-265702 001-36510 251451725 34 1080404 1 1
2025-10-14 8-K 8-K 8.01,9.01 0001193125-25-237998 001-36510 251389571 34 23939190 1 1
2025-09-29 8-K 8-K 8.01,9.01 0001193125-25-221538 001-36510 251352066 34 2722693 1 1
2025-08-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-025979 005-88225 251280812 34 22519
2025-08-14 10-Q 10-Q 0000950170-25-108797 001-36510 251218077 34 8433396 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000204 005-88225 251215479 34 9676
2025-08-14 8-K 8-K 2.02,8.01,9.01 0000950170-25-108409 001-36510 251214242 34 27692894 1 1
2025-08-04 4 xslF345X05/e664762_4-larimar.xml 0001193805-25-001155 36935
2025-07-31 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193805-25-001138 005-88225 251173154 34 35897
2025-07-31 8-K 8-K 1.01,9.01 0001193125-25-169818 001-36510 251169144 34 463883 1 1
2025-07-31 424B5 424B5 0001193125-25-169661 333-279275 251169028 33 2923814
2025-07-29 8-K 8-K 2.02 0001193125-25-168096 001-36510 251162758 34 137727 1 1
2025-07-29 424B5 424B5 0001193125-25-168035 333-279275 251162301 33 2960009
2025-06-23 8-K 8-K 8.01,9.01 0000950170-25-089074 001-36510 251065853 34 26648317 1 1
2025-06-23 8-K 8-K 8.01,9.01 0000950170-25-088704 001-36510 251062946 34 7973310 1 1
2025-06-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-060256 005-88225 251053433 34 15132
2025-05-15 4 xslF345X05/e664519_4-larimar.xml 0001193805-25-000672 12904
2025-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-009380 5485
2025-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-009379 5493
2025-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-009378 5457
2025-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-009377 5496
2025-05-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-009376 5975
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000147 005-88225 25943924 34 10802
2025-05-13 8-K 8-K 5.07 0000950170-25-070287 001-36510 25939891 34 167517 1 1
2025-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000769993-25-000286 005-88225 25938194 34 16865
2025-05-05 8-K 8-K 8.01,9.01 0000950170-25-063125 001-36510 25910826 34 26518834 1 1
2025-04-30 10-Q 10-Q 0000950170-25-061222 001-36510 25896761 34 7701365 1 1
2025-04-30 8-K 8-K 2.02,9.01 0000950170-25-060563 001-36510 25890880 34 678284 1 1
2025-04-22 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-000404 005-88225 25857112 34 11259
2025-04-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-005093 005-88225 25843545 34 22367
2025-04-11 ARS ARS 0000950170-25-053030 001-36510 25829877 34 2150166
2025-04-11 DEF 14A DEF 14A 0000950170-25-053028 001-36510 25829872 34 12049475 1 1
2025-03-24 S-8 S-8 0001193125-25-061462 333-286062 25765128 33 70757
2025-03-24 10-K 10-K 0000950170-25-043925 001-36510 25764836 34 14347326 1 1
2025-03-24 8-K 8-K 2.02,8.01,9.01 0000950170-25-043487 001-36510 25762199 34 26944996 1 1
2025-02-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-000662 005-88225 25587863 34 11949
2025-01-27 8-K 8-K 5.02,9.01 0000950170-25-009196 001-36510 25559148 34 223362 1 1
2025-01-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-001080 7316
2025-01-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-001079 7254
2025-01-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-001078 11096
2025-01-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-001077 7262
2025-01-10 8-K 8-K 8.01,9.01 0000950170-25-003794 001-36510 25520403 34 27257358 1 1
2025-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000006 005-88225 25517243 34 10855
2024-12-16 8-K 8-K 8.01,9.01 0000950170-24-136384 001-36510 241550114 34 27990077 1 1
2024-11-18 8-K 8-K 8.01,9.01 0000950170-24-127768 001-36510 241469743 34 23917621 1 1
2024-11-14 SC 13G/A SC 13G/A 0001140361-24-046973 005-88225 241464096 34 51461
2024-11-14 SC 13G/A JANUS AMENDMENT 0001274173-24-000112 005-88225 241458912 34 13236
2024-11-14 SC 13G/A sadaveritionlarimar_sc13ga1.htm 0000905148-24-003078 005-88225 241457686 34 97898
2024-11-06 SC 13G LARIMARTHERAP.txt 0000769993-24-000350 005-88225 241430276 34 23932
2024-10-30 10-Q 10-Q 0000950170-24-119100 001-36510 241411289 34 6841705 1 1
2024-10-30 8-K 8-K 2.02,8.01,9.01 0000950170-24-118586 001-36510 241407413 34 21364234 1 1
2024-08-08 10-Q 10-Q 0000950170-24-093733 001-36510 241187623 34 6633019 1 1
2024-08-07 8-K 8-K 2.02,8.01,9.01 0000950170-24-092265 001-36510 241181375 34 23170997 1 1
2024-06-10 8-K 8-K 8.01,9.01 0000950170-24-071056 001-36510 241031401 34 22610904 1 1
2024-06-03 4 xslF345X05/e663682_4-larimar.xml 0001193805-24-000743 13402
2024-05-31 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-011572 5503
2024-05-31 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-011571 5982
2024-05-31 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-011570 5492
2024-05-31 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-011569 5500
2024-05-31 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-011568 7840
2024-05-31 8-K 8-K 5.07 0000950170-24-067306 001-36510 241009701 34 196581 1 1
2024-05-30 8-K 8-K 8.01,9.01 0000950170-24-066571 001-36510 241005270 34 543396 1 1
2024-05-24 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-24 16:01:00 9999999995-24-001647 333-279275 24986124 33 1928
2024-05-22 CORRESP filename1.htm 0001193125-24-145160 6942
2024-05-20 8-K 8-K 8.01,9.01 0000950170-24-062387 001-36510 24964482 34 22177600 1 1
2024-05-16 UPLOAD filename1.pdf 0000000000-24-005680 333-279275 40543
2024-05-09 S-3 S-3 0001193125-24-135337 333-279275 24931555 33 2687356
2024-05-09 10-Q 10-Q 0000950170-24-056965 001-36510 24930721 34 6498893 1 1
2024-05-09 8-K 8-K 2.02,8.01,9.01 0000950170-24-056248 001-36510 24928480 34 23710176 1 1
2024-04-29 ARS ARS 0001193125-24-122206 001-36510 24890547 34 10541778
2024-04-29 DEF 14A DEF 14A 0001193125-24-122191 001-36510 24890485 34 2137000
2024-04-12 PRE 14A PRE 14A 0001193125-24-093837 001-36510 24839888 34 2168481
2024-03-15 SC 13D/A e619370_sc13da-lt.htm 0001193805-24-000378 005-88225 24755429 34 201517
2024-03-14 S-8 S-8 0001193125-24-068011 333-277946 24751200 33 76407
2024-03-14 S-8 S-8 0001193125-24-068008 333-277945 24751193 33 80544
2024-03-14 10-K 10-K 0000950170-24-031529 001-36510 24750565 34 11277054 1 1
2024-03-14 8-K 8-K 2.02,9.01 0000950170-24-031467 001-36510 24749757 34 664205 1 1
2024-03-11 8-K 8-K 8.01,9.01 0000950170-24-029236 001-36510 24738064 34 34477596 1 1
2024-02-26 SC 13G SC 13G 0001104659-24-027515 005-88225 24678951 34 92955
2024-02-16 8-K 8-K 1.01,9.01 0001193125-24-038473 001-36510 24648343 34 467135 1 1
2024-02-16 4 xslF345X05/e619284_4-larimar.xml 0001193805-24-000245 37578
2024-02-16 SC 13D/A e619283_sc13da-lt.htm 0001193805-24-000244 005-88225 24647448 34 212800
2024-02-15 SC 13D/A e619280_sc13da-lt.htm 0001193805-24-000234 005-88225 24644881 34 242262
2024-02-15 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-003312 4559
2024-02-14 SC 13G SC 13G 0001140361-24-008095 005-88225 24641726 34 48997
2024-02-14 424B5 424B5 0001193125-24-036565 333-268312 24640386 33 594334
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036429 005-88225 24639647 34 64572
2024-02-14 SC 13G SC 13G 0001140361-24-007732 005-88225 24632721 34 92702
2024-02-14 8-K 8-K 1.02 0000950170-24-014919 001-36510 24631865 34 144318 1 1
2024-02-13 SC 13G/A JHG PLC & JHBIF >5% 0001274173-24-000054 005-88225 24630297 34 13384
2024-02-13 424B5 424B5 0001193125-24-033870 333-268312 24626918 33 629980
2024-02-12 8-K 8-K 2.02,8.01,9.01 0000950170-24-013563 001-36510 24617342 34 35031957 1 1
2024-01-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-001086 7316
2024-01-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-001085 7262
2024-01-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-001084 7254
2024-01-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-001083 7301
2023-12-08 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022200 5113
2023-11-14 10-Q 10-Q 0000950170-23-063517 001-36510 231404101 34 7248094 1 1
2023-11-14 8-K 8-K 2.02,8.01,9.01 0000950170-23-063347 001-36510 231401556 34 23407017 1 1
2023-10-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019067 5407
2023-10-05 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-019065 5716
2023-10-03 8-K 8-K 5.02 0001193125-23-249962 001-36510 231304281 34 149423 1 1
2023-08-18 SC 13G JHG PLC OWNS 5.1% LARIMAR 0001274173-23-000087 005-88225 231185485 34 13042
2023-08-14 8-K 8-K 8.01,9.01 0000950170-23-042070 001-36510 231166391 34 21881975 1 1
2023-08-10 10-Q 10-Q 0000950170-23-041293 001-36510 231159253 34 7781043 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-040946 001-36510 231157136 34 761210 1 1
2023-07-25 8-K 8-K 8.01,9.01 0000950170-23-034217 001-36510 231106430 34 7478183 1 1
2023-07-24 144 xsl144X01/primary_doc.xml 0001972362-23-000497 001-36510 231105955 33 4278
2023-07-18 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-014993 5498
2023-07-18 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-014992 5756
2023-07-17 8-K 8-K 8.01,9.01 0000950170-23-033196 001-36510 231091718 34 558283 1 1
2023-06-01 8-K 8-K 8.01,9.01 0000950170-23-025691 001-36510 23984693 34 21718705 1 1
2023-05-18 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-011547 5058
2023-05-18 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-011546 4540
2023-05-18 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-011545 4476
2023-05-15 10-Q 10-Q 0000950170-23-022187 001-36510 23921885 34 6628829 1 1
2023-05-15 8-K 8-K 2.02,8.01,9.01 0000950170-23-021953 001-36510 23918335 34 8879473 1 1
2023-05-12 8-K 8-K 5.07 0000950170-23-021747 001-36510 23915470 34 216566 1 1
2023-05-11 4 xslF345X04/e618621_4-larimar.xml 0001193805-23-000711 12867
2023-05-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-010808 5413
2023-05-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-010807 5377
2023-05-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-010806 5895
2023-05-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-010805 5416
2023-04-11 ARS ARS 0001193125-23-097802 001-36510 23813501 34 2932785
2023-04-11 DEF 14A DEF 14A 0001193125-23-097798 001-36510 23813461 34 1692091
2023-04-06 8-K 8-K 5.02 0001193125-23-093965 001-36510 23806201 34 138727 1 1
2023-03-17 SC 13D/A e618373_sc13da-lt.htm 0001193805-23-000345 005-88225 23739999 34 210919
2023-03-14 S-8 S-8 0001193125-23-070249 333-270536 23732005 33 75550
2023-03-14 S-8 S-8 0001193125-23-070247 333-270535 23731993 33 58541
2023-03-14 10-K 10-K 0000950170-23-007855 001-36510 23730679 34 10675789 1 1
2023-03-14 8-K 8-K 2.02,8.01,9.01 0001193125-23-069624 001-36510 23729189 34 14359649 1 1
2023-02-14 SC 13G SC 13G 0001193125-23-038711 005-88225 23627210 34 63498
2023-02-13 SC 13G/A CHI ADVISORS LLC 0001085146-23-001072 005-88225 23616021 34 28087
2023-02-09 4 FORM 4 SUBMISSION 0000899243-23-004438 5732
2023-02-09 3 FORM 3 SUBMISSION 0000899243-23-004434 6267
2023-02-07 8-K 8-K 8.01,9.01 0001193125-23-026958 001-36510 23595362 34 180080 1 1
2023-02-02 4 FORM 4 SUBMISSION 0000899243-23-003735 7507
2023-02-02 4 FORM 4 SUBMISSION 0000899243-23-003734 7547
2023-01-23 SC 13G/A formsc13ga.htm 0001493152-23-002084 005-88225 23542259 34 94036
2023-01-09 8-K 8-K 8.01,9.01 0000950170-23-000506 001-36510 23518096 34 17112488 1 1
2022-11-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-11-21 16:01:00 9999999995-22-003366 333-268312 221407367 33 1880
2022-11-18 CORRESP filename1.htm 0001193125-22-288978 6404
2022-11-16 UPLOAD filename1.pdf 0000000000-22-012442 40375
2022-11-14 SC 13G/A SC 13G/A 0001104659-22-118669 005-88225 221386795 34 79101
2022-11-10 S-3 S-3 0001193125-22-282600 333-268312 221378588 33 1041661
2022-11-10 10-Q 10-Q 0000950170-22-024223 001-36510 221375297 34 7098544 1 1
2022-11-10 8-K 8-K 2.02,8.01,9.01 0000950170-22-024139 001-36510 221374856 34 3522717 1 1
2022-10-20 8-K 8-K 8.01,9.01 0000950170-22-019769 001-36510 221319805 34 3361457 1 1
2022-09-20 4 xslF345X03/e621937_4-larimar.xml 0001193805-22-001296 32356
2022-09-20 3 xslF345X02/e621936_3-lt.xml 0001193805-22-001295 10653
2022-09-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-019753 5388
2022-09-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-019646 4744
2022-09-19 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-019645 4784
2022-09-16 SC 13D/A e621926_sc13da-lt.htm 0001193805-22-001271 005-88225 221248792 34 233978
2022-09-14 8-K 8-K 1.01,8.01,9.01 0001193125-22-244317 001-36510 221242157 34 439497 1 1
2022-09-14 424B5 424B5 0001193125-22-244264 333-246370 221242074 33 522446
2022-09-14 8-K 8-K 8.01,9.01 0001193125-22-244248 001-36510 221242064 34 12508196 1 1
2022-08-11 10-Q 10-Q 0000950170-22-016917 001-36510 221156409 34 7271356 1 1
2022-08-11 8-K 8-K 2.02,8.01,9.01 0000950170-22-016881 001-36510 221156019 34 4043148 1 1
2022-05-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012309 5506
2022-05-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012308 5466
2022-05-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012307 5382
2022-05-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012306 5379
2022-05-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012305 5346
2022-05-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012304 5864
2022-05-12 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-012303 5385
2022-05-12 8-K 8-K 5.02,5.07 0001193125-22-148643 001-36510 22917902 34 154075 1 1
2022-05-12 10-Q 10-Q 0000950170-22-009590 001-36510 22917190 34 5501116 1 1
2022-05-12 8-K 8-K 2.02,8.01,9.01 0001193125-22-148057 001-36510 22915684 34 14725903 1 1
2022-05-11 4 xslF345X03/e621645_4-larimar.xml 0001193805-22-000771 12749
2022-04-12 DEF 14A DEF 14A 0001193125-22-102289 001-36510 22821039 34 1436863
2022-04-11 8-K FORM 8-K 5.02 0001193125-22-101650 001-36510 22819745 34 144338 1 1
2022-03-25 10-K 10-K 0000950170-22-004637 001-36510 22769604 34 11034605 1 1
2022-03-25 8-K 8-K 2.02,8.01,9.01 0001193125-22-084528 001-36510 22768211 34 13323497 1 1
2022-02-28 8-K 8-K 2.02,8.01,9.01 0001193125-22-055857 001-36510 22684011 34 13499942 1 1
2022-02-18 SC 13G formsc13g.htm 0001493152-22-004967 005-88225 22653323 34 93083
2022-02-15 SC 13G/A larimar13ga1.htm 0000935836-22-000194 005-88225 22638642 34 37957
2022-02-14 8-K 8-K 8.01,9.01 0001193125-22-042209 001-36510 22634798 34 164901 1 1
2022-02-14 SC 13G/A LARIMAR THERAPEUTICS, INC. 0001104659-22-022752 005-88225 22631914 34 90713
2022-02-11 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001213900-22-007092 005-88225 22622934 34 99894
2022-02-11 SC 13G/A AMENDMENT NO. 1 0000947871-22-000203 005-88225 22621577 34 65806
2022-02-11 SC 13G/A CHI ADVISORS LLC 0001085146-22-000831 005-88225 22618046 34 28056
2022-01-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-001320 5469
2022-01-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-001319 5512
2021-11-12 10-Q 10-Q 0000950170-21-004331 001-36510 211402093 34 8108003 1 1
2021-11-12 8-K 8-K 2.02,8.01,9.01 0001193125-21-327323 001-36510 211399554 34 14811005 1 1
2021-08-12 8-K 8-K 2.02,8.01,9.01 0001193125-21-244068 001-36510 211165906 34 16012293 1 1
2021-08-12 10-Q 10-Q 0001564590-21-043701 001-36510 211165902 34 7249404 1 1
2021-07-02 SC 13D/A e620771_sc13da-lt.htm 0001193805-21-000975 005-88225 211071368 34 159068
2021-07-02 4 xslF345X03/e620772_4-larimar.xml 0001193805-21-000974 30993
2021-07-02 4 PRIMARY DOCUMENT 0001192482-21-000601 5111
2021-07-01 8-K 8-K 8.01,9.01 0001193125-21-205474 001-36510 211063934 34 10810294 1 1
2021-06-14 8-K 8-K 8.01,9.01 0001193125-21-190213 001-36510 211015566 34 10600498
2021-05-26 SC 13D/A e620639_sc13da-lt.htm 0001193805-21-000725 005-88225 21964644 34 134399
2021-05-26 8-K 8-K 1.02,8.01,9.01 0001193125-21-173167 001-36510 21963250 34 40751
2021-05-21 SC 13D/A e620626_sc13da-lt.htm 0001193805-21-000700 005-88225 21950071 34 169192
2021-05-21 8-K 8-K 1.01,3.02,9.01 0001193125-21-168704 001-36510 21946823 34 495874
2021-05-21 8-K 8-K 8.01,9.01 0001193125-21-168548 001-36510 21946594 34 37218
2021-05-20 4 PRIMARY DOCUMENT 0001192482-21-000445 5388
2021-05-18 8-K 8-K 8.01,9.01 0001193125-21-165178 001-36510 21935701 34 15212717
2021-05-17 4 xslF345X03/e620613_4-larimar.xml 0001193805-21-000685 12972
2021-05-17 4 PRIMARY DOCUMENT 0001192482-21-000442 5869
2021-05-17 4 PRIMARY DOCUMENT 0001192482-21-000441 5376
2021-05-17 4 PRIMARY DOCUMENT 0001192482-21-000440 5385
2021-05-17 4 PRIMARY DOCUMENT 0001192482-21-000439 5391
2021-05-17 4 PRIMARY DOCUMENT 0001192482-21-000438 5352
2021-05-17 8-K 8-K 5.07 0001193125-21-162647 001-36510 21927291 34 25489
2021-05-11 8-K 8-K 8.01,9.01 0001193125-21-157048 001-36510 21909761 34 9441834
2021-05-10 10-Q 10-Q 0001564590-21-026084 001-36510 21907671 34 6349055 1
2021-05-10 8-K 8-K 2.02,9.01 0001193125-21-156249 001-36510 21907381 34 77890
2021-04-14 DEF 14A DEF 14A 0001193125-21-115586 001-36510 21824650 34 1528976
2021-03-04 8-K/A 8-K/A 9.01 0001193125-21-069725 001-36510 21715279 34 161014
2021-03-04 10-K 10-K 0001564590-21-011003 001-36510 21715184 34 8133956 1
2021-03-04 8-K 8-K 2.02,9.01 0001193125-21-068478 001-36510 21712583 34 90430
2021-03-02 SC 13G CHI ADVISORS LLC 0001085146-21-001060 005-88225 21702617 34 27991
2021-02-16 SC 13G larimar13ga.htm 0000935836-21-000176 005-88225 21639973 34 60355
2021-02-16 SC 13G SCHEDULE 13G 0001104659-21-024228 005-88225 21639673 34 91749
2021-02-16 SC 13G/A larimar13ga2-021621.htm 0001013594-21-000163 005-88225 21636839 34 73694
2021-02-16 SC 13G/A AMENDMENT NO. 1 0001214659-21-001842 005-88225 21635314 34 51908
2021-02-16 SC 13G/A SC 13G/A 0001178913-21-000597 005-88225 21633036 34 89659
2021-02-16 SC 13G form-sc13g.htm 0001493152-21-003768 005-88225 21631866 34 123453
2021-02-12 SC 13G SCEDULE 13G 0000947871-21-000178 005-88225 21628971 34 66875
2021-02-11 SC 13G/A lrmr-13g_20201231.txt 0001037389-21-000115 005-88225 21615771 34 13504
2021-02-02 SC 13G/A SC 13G/A 0001104659-21-010775 005-88225 21580025 34 125093
2021-01-21 4 PRIMARY DOCUMENT 0001192482-21-000075 5521
2021-01-21 4 PRIMARY DOCUMENT 0001192482-21-000074 5478
2020-12-08 8-K 8-K 7.01,8.01,9.01 0001193125-20-312288 001-36510 201374409 34 12490699
2020-11-12 8-K/A 8-K/A 9.01 0001193125-20-291777 001-36510 201307629 34 159852
2020-11-12 10-Q 10-Q 0001564590-20-053618 001-36510 201307427 34 6008839 1
2020-11-10 8-K 8-K 2.02,7.01,9.01 0001193125-20-290185 001-36510 201301468 34 7786350
2020-10-30 8-K 8-K 1.01,9.01 0001193125-20-282731 001-36510 201278090 34 443235
2020-10-02 S-8 FORM S-8 0001193125-20-262644 333-249287 201221241 33 89771
2020-10-01 4 xslF345X03/e619973_4-larimar.xml 0001193805-20-001219 13033
2020-09-30 4 PRIMARY DOCUMENT 0001192482-20-000751 5526
2020-09-30 4 PRIMARY DOCUMENT 0001192482-20-000749 5550
2020-09-30 4 PRIMARY DOCUMENT 0001192482-20-000747 5559
2020-09-30 4 PRIMARY DOCUMENT 0001192482-20-000745 5570
2020-09-30 4 PRIMARY DOCUMENT 0001192482-20-000742 5562
2020-09-30 4 PRIMARY DOCUMENT 0001192482-20-000740 6043
2020-09-30 4 PRIMARY DOCUMENT 0001192482-20-000738 5565
2020-09-30 4 PRIMARY DOCUMENT 0001192482-20-000736 5613
2020-09-29 8-K/A 8-K/A 5.02,5.07,9.01 0001193125-20-257868 001-36510 201209324 34 116548
2020-09-29 8-K 8-K 5.02,5.07,9.01 0001193125-20-257168 001-36510 201206001 34 114692
2020-09-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-09-01 16:00:00 9999999995-20-002332 333-246370 201155626 33 1880
2020-08-31 CORRESP filename1.htm 0001193125-20-236337 8151
2020-08-24 UPLOAD filename1.pdf 0000000000-20-007931 40416
2020-08-19 DEFA14A DEFA14A 0001193125-20-224092 001-36510 201115284 34 248300
2020-08-19 DEF 14A DEF 14A 0001193125-20-224087 001-36510 201115280 34 489967
2020-08-14 S-3 S-3 0001193125-20-220606 333-246370 201106748 33 964172
2020-08-14 8-K/A 8-K/A 9.01 0001193125-20-220561 001-36510 201106282 34 157704
2020-08-14 10-Q 10-Q 0001564590-20-040314 001-36510 201106122 34 6428150 1
2020-08-11 8-K FORM 8-K 2.02,7.01,9.01 0001193125-20-215639 001-36510 201091067 34 7760832
2020-08-06 8-K FORM 8-K 5.02,7.01,9.01 0001193125-20-211426 001-36510 201080135 34 7826480
2020-07-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-07-14 16:01:00 9999999995-20-001802 333-239510 201028205 33 1880
2020-07-13 CORRESP filename1.htm 0001193125-20-192119 6682
2020-07-10 UPLOAD filename1.pdf 0000000000-20-006250 44582
2020-07-01 SC 13D/A e619740_sc13da-lt.htm 0001193805-20-000766 005-88225 201005366 34 183620
2020-06-30 4 PRIMARY DOCUMENT 0001192482-20-000588 6357
2020-06-30 4 PRIMARY DOCUMENT 0001192482-20-000587 4919
2020-06-30 4 PRIMARY DOCUMENT 0001192482-20-000586 4852
2020-06-30 SC 13D/A SC 13D/A 0001193125-20-184105 005-88225 201002815 34 30940
2020-06-26 S-3 FORM S-3 0001193125-20-181162 333-239510 20995258 33 409508
2020-06-26 S-8 S-8 0001193125-20-181158 333-239509 20995238 33 135106
2020-06-26 8-K/A 8-K/A 8.01,9.01 0001193125-20-181113 001-36510 20994993 34 1095215
2020-06-11 SC 13G SCHEDULE 13G 0001213900-20-014711 005-88225 20957900 34 110814
2020-06-10 D xslFormDX01/primary_doc.xml 06b 0001192482-20-000457 021-368642 20954258 33 12084
2020-06-10 D xslFormDX01/primary_doc.xml 06b 0001192482-20-000456 021-368640 20954254 33 13262
2020-06-08 3 xslF345X02/e619691_3-lt.xml 0001193805-20-000673 26471
2020-06-08 SC 13D SC 13D 0001193125-20-163701 005-88225 20950050 34 45247
2020-06-08 SC 13D e619689_sc13d-lt.htm 0001193805-20-000670 005-88225 20949883 34 348184
2020-06-05 3 PRIMARY DOCUMENT 0001192482-20-000439 3893
2020-06-05 4 PRIMARY DOCUMENT 0001192482-20-000435 5474
2020-06-05 3 PRIMARY DOCUMENT 0001192482-20-000433 5838
2020-06-05 3 PRIMARY DOCUMENT 0001192482-20-000430 8571
2020-06-05 3 PRIMARY DOCUMENT 0001192482-20-000427 5831
2020-06-05 3 PRIMARY DOCUMENT 0001192482-20-000424 5814
2020-06-05 3 PRIMARY DOCUMENT 0001192482-20-000422 5795
2020-06-05 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-20-005502 005-88225 20946543 34 89720
2020-06-03 8-K FORM 8-K 7.01,9.01 0001193125-20-158916 001-36510 20938761 34 6997845
2020-06-02 8-K 8-K 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.07,9.01 0001193125-20-157924 001-36510 20935604 34 694824
2020-05-19 DEFA14A DEFA14A 0001193125-20-145379 001-36510 20891490 34 22078
2020-05-07 10-Q 10-Q 0001564590-20-022942 001-36510 20857084 34 6229281 1
2020-04-30 UPLOAD filename1.pdf 0000000000-20-003699 39885
2020-04-29 DEFM14A DEFM14A 0001193125-20-125890 001-36510 20829718 34 4087096
2020-04-27 CORRESP filename1.htm 0001193125-20-120405 19397
2020-04-27 PRER14A PRER14A 0001193125-20-120402 001-36510 20817480 34 3955586
2020-04-24 8-K 8-K 3.01 0001193125-20-119225 001-36510 20815875 34 20171
2020-04-24 UPLOAD filename1.pdf 0000000000-20-003534 44184
2020-04-10 CORRESP filename1.htm 0001193125-20-103896 27655
2020-04-10 PRER14A PRER14A 0001193125-20-103893 001-36510 20787016 34 3946578
2020-04-06 UPLOAD filename1.pdf 0000000000-20-002953 48649
2020-03-09 8-K 8-K 1.01,9.01 0001193125-20-065288 001-36510 20696083 34 48989
2020-03-09 DEFA14A 8-K 0001193125-20-065289 001-36510 20696075 34 48879
2020-03-06 PREM14A PREM14A 0001193125-20-065266 001-36510 20695961 34 3869198
2020-03-05 S-8 S-8 0001193125-20-063154 333-236917 20691372 33 49676
2020-03-05 10-K 10-K 0001564590-20-008984 001-36510 20691228 34 11737000 1
2020-03-05 8-K 8-K 2.02,9.01 0001193125-20-063097 001-36510 20691001 34 109066
2020-02-14 SC 13G/A greatpoint-zfgn123119a2.htm 0001172661-20-000851 005-88225 20620267 34 109000
2020-02-14 SC 13G ZAFGEN 0001214659-20-001478 005-88225 20619100 34 50533
2020-02-14 SC 13G/A zafgen13ga2019.htm 0000935836-20-000136 005-88225 20617721 34 48047
2020-02-14 SC 13G/A d8477762_13g-a.htm 0000919574-20-001448 005-88225 20615951 34 119607
2020-02-13 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0001013594-20-000130 005-88225 20607458 34 81313
2020-02-12 SC 13G zfgn-13g_20191231.txt 0001037389-20-000021 005-88225 20602259 34 13283
2020-02-11 SC 13G SC 13G 0001178913-20-000349 005-88225 20595437 34 114931
2020-02-05 DEFA14A DEFA14A 0001193125-20-025418 001-36510 20579206 34 4146925
2020-02-05 8-K 8-K 7.01,9.01 0001193125-20-025413 001-36510 20579185 34 5747617
2020-02-04 SC 13G/A SC 13G/A 0001104659-20-010544 005-88225 20573252 34 40270
2020-01-13 8-K 8-K 7.01,8.01,9.01 0001193125-20-005893 001-36510 20522762 34 7590638
2020-01-13 DEFA14A 8-K 0001193125-20-005894 001-36510 20522752 34 7590514
2019-12-27 SC 13D SCHEDULE 13D 0001193125-19-325057 005-88225 191315047 34 53685
2019-12-19 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-19-009675 005-88225 191294915 34 95541
2019-12-18 DEFA14A DEFA14A 0001193125-19-317565 001-36510 191292836 34 60317
2019-12-18 8-K 8-K 1.01,3.02,5.01,8.01,9.01 0001193125-19-316828 001-36510 191291324 34 7866596
2019-12-18 DEFA14A 8-K 0001193125-19-316829 001-36510 191291301 34 7866343
2019-11-07 S-8 S-8 0001193125-19-287477 333-234579 191201423 33 67907
2019-11-06 10-Q 10-Q 0001564590-19-041090 001-36510 191196894 34 7745469 1
2019-11-06 8-K 8-K 2.02,9.01 0001193125-19-285939 001-36510 191196746 34 89067
2019-10-15 SC 13G zafgen13g.htm 0000935836-19-000550 005-88225 191151538 34 48069
2019-10-10 SC 13G/A filing.txt 0000315066-19-001729 005-88225 191145706 34 7180
2019-09-19 8-K 8-K 3.01 0001193125-19-249639 001-36510 191102187 34 19672
2019-09-18 SC 13G/A AMENDED FORM SC 13G 0001387131-19-007012 005-88225 191099724 34 96970
2019-09-16 SC 13G SEPTEMBER 5, 2019 0001013594-19-000528 005-88225 191095076 34 97318
2019-09-12 8-K 8-K 2.05,5.02,9.01 0001193125-19-244019 001-36510 191091008 34 90889
2019-08-16 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-19-006222 005-88225 191032530 34 94740
2019-08-08 10-Q 10-Q 0001564590-19-030904 001-36510 191010534 34 6950549 1
2019-08-08 8-K 8-K 2.02,9.01 0001193125-19-216900 001-36510 191010049 34 94482
2019-07-10 SC 13G/A us98885e1038_071019.txt 0000215457-19-008360 005-88225 19949605 34 12206
2019-06-27 4 FORM 4 SUBMISSION 0000899243-19-018485 5561
2019-06-27 4 FORM 4 SUBMISSION 0000899243-19-018483 5594
2019-06-27 4 FORM 4 SUBMISSION 0000899243-19-018481 5565
2019-06-27 4 FORM 4 SUBMISSION 0000899243-19-018480 5571
2019-06-27 4 FORM 4 SUBMISSION 0000899243-19-018479 5560
2019-06-27 4 FORM 4 SUBMISSION 0000899243-19-018476 5569
2019-06-27 4 FORM 4 SUBMISSION 0000899243-19-018474 5555
2019-06-13 8-K 8-K 5.07 0001193125-19-172590 001-36510 19896858 34 23397
2019-05-30 8-K 8-K 7.01,9.01 0001193125-19-160233 001-36510 19864570 34 36082
2019-05-09 10-Q 10-Q 0001564590-19-018086 001-36510 19811539 34 6541423 1
2019-05-09 8-K 8-K 2.02,9.01 0001193125-19-143016 001-36510 19810947 34 98014
2019-04-26 DEF 14A DEF 14A 0001193125-19-122675 001-36510 19772870 34 371017
2019-04-04 4 FORM 4 SUBMISSION 0000899243-19-010033 5753

Latest XBRL company facts

One latest value per concept from companyfacts (313 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 104.63M 2026-11-10 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
dei EntityPublicFloat Entity Public Float USD 94.67M 2025-06-30 2025 FY 10-K 2026-03-19 0001193125-26-115878
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.05M 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001193125-26-163942
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.50M 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001193125-26-163942
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 2.14M 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001193125-26-163942
ecd PeoTotalCompAmt PeoTotalCompAmt USD 3.53M 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001193125-26-163942
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 36.24 2025-01-01 2025-12-31 DEF 14A 2026-04-20 0001193125-26-163942
ffd NetFeeAmt NetFeeAmt USD 229.55 2026-11-13 S-8 2026-11-16 0001193125-26-463459
ffd TtlFeeAmt TtlFeeAmt USD 229.55 2026-11-13 S-8 2026-11-16 0001193125-26-463459
ffd TtlOfferingAmt TtlOfferingAmt USD 2.64M 2026-11-13 S-8 2026-11-16 0001193125-26-463459
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-13 S-8 2026-11-16 0001193125-26-463459
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 5.11M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 985,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 1.19M 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 29.16M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 924,000 2020-12-31 2021 FY 10-K 2022-03-25 0000950170-22-004637
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 2.08M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -19,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 629.74M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 512.78M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.17M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063517
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD -425,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-04 0001193125-26-331529
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 43,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-10 0001193125-17-078784
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 12.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap Assets Assets USD 140.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AssetsCurrent Assets, Current USD 136.15M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 123.48M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 54,000 2025-12-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 19,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 51.69M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 51.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 51.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 11.71M 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056965
us-gaap AvailableForSaleSecuritiesGrossRealizedGainLossNet Available-for-sale Securities, Gross Realized Gain (Loss) USD 341,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-14 0001193125-15-188267
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 40.59M 2020-05-28 2021 FY 10-K 2022-03-25 0000950170-22-004637
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities USD 1.01M 2020-05-28 2021 FY 10-K 2022-03-25 0000950170-22-004637
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities USD 2.69M 2020-05-28 2021 FY 10-K 2022-03-25 0000950170-22-004637
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 38.83M 2020-05-28 2021 FY 10-K 2022-03-25 0000950170-22-004637
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 398,000 2020-05-28 2021 FY 10-K 2022-03-25 0000950170-22-004637
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 13,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-04 0001193125-26-331529
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 41.93M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0000950170-22-004637
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 76.99M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 71.81M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 8.55M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007863
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 128.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 77.44M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -8.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 62.60M 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009590
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.01 2023-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-041293
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 628,403 2023-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-041293
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 215.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 104.63M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 104.63M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap CommonStockValue Common Stock, Value, Issued USD 104,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -93.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -13.48M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-14 0001193125-15-188267
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 104.33M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-10 0001193125-17-078784
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 15.08M 2014-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 6.09M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid USD 1.29M 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 14,000 2016-09-30 2016 Q3 10-Q 2016-11-09 0001193125-16-764420
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 148,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-10 0001193125-17-078784
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0000950170-23-022187
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 617,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 148,000 2014-12-31 2015 FY 10-K 2016-03-15 0001193125-16-505173
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 233.42M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 66.66M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2022-12-31 2022 FY 10-K 2023-03-14 0000950170-23-007855
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 437,000 2014-12-31 2015 FY 10-K 2016-03-15 0001193125-16-505173
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 114.37M 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 93.10M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 16.60M 2018-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007863
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 3.40M 2018-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007863
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 30,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 41.97M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 5.88M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 431,000 2014-12-31 2015 FY 10-K 2016-03-15 0001193125-16-505173
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements USD 2.12M 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 19,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 232.80M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 617,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 100,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001193125-18-077456
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.03 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap Depreciation Depreciation USD 183,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.5 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266969
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.76 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001564590-21-026084
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.5 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266969
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.291 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.013 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.008 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.001 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.055 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.002 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure -0.032 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.084 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.62M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 11.80M 2022-12-31 2022 FY 10-K 2023-03-14 0000950170-23-007855
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2017-09-30 2017 Q3 10-Q 2017-11-07 0001193125-17-335910
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-377065
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 4.82M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0000950170-22-004637
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -210,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -29,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 1,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-25 0000950170-22-004637
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 1,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0000950170-23-007855
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -6,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041090
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 18.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007863
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 100,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -165.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -165.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD -1,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043925
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 1.32M 2015-12-31 2015 FY 10-K 2016-03-15 0001193125-16-505173
us-gaap IncomeTaxesReceivableNoncurrent Income Taxes Receivable, Noncurrent USD 975,000 2015-09-30 2015 Q3 10-Q 2015-11-13 0001193125-15-377065
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 48.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -34.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 486,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 13.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -108,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -29.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -2.19M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap IncreaseDecreaseInIncomeTaxesReceivable Increase (Decrease) in Income Taxes Receivable USD -368,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-13 0001193125-14-411306
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -437,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024223
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap IncreaseDecreaseInRestructuringReserve Increase (Decrease) in Restructuring Reserve USD -1.73M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap InterestExpense Interest Expense USD 301,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 198,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-159281
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 212,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 500,000 2018-09-30 2018 Q3 10-Q 2018-11-09 0001564590-18-028944
us-gaap InterestReceivable Interest Receivable USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 216,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 246,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001193125-18-077456
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 258,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap InvestmentIncomeNet Investment Income, Net USD 642,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001564590-19-018086
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 5,000 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001564590-21-026084
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 3.57M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-10 0001193125-17-078784
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 52,000 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001193125-14-310145
us-gaap LeaseCost Lease, Cost USD 303,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 5.62M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043925
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.83M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 959,000 2024-12-31 2024 FY 10-K 2025-03-24 0000950170-25-043925
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 959,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.53M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.75M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 454,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 842,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap Liabilities Liabilities USD 39.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 140.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap LiabilitiesCurrent Liabilities, Current USD 35.65M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap LineOfCredit Long-term Line of Credit USD 0 2013-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap LineOfCreditFacilityAverageOutstandingAmount Line of Credit Facility, Average Outstanding Amount USD 0 2013-12-31 2014 Q2 10-Q 2014-08-14 0001193125-14-310145
us-gaap LineOfCreditFacilityInterestRateDuringPeriod Line of Credit Facility, Interest Rate During Period pure 0.081 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-10 0001193125-17-078784
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 20.00M 2014-03-31 2015 FY 10-K 2016-03-15 0001193125-16-505173
us-gaap LineOfCreditFacilityPeriodicPaymentInterest Line of Credit Facility, Periodic Payment, Interest USD 426,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-14 0001193125-15-291736
us-gaap LongTermDebt Long-term Debt USD 14.54M 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 7.27M 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 7.27M 2018-09-30 2018 Q3 10-Q 2018-11-09 0001564590-18-028944
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 7.27M 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041090
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 7.27M 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 1.82M 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041090
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 6.75M 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap MarketableSecurities Marketable Securities USD 0 2023-03-31 2023 Q1 10-Q 2023-05-15 0000950170-23-022187
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 11,000 2019-07-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041090
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 110.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 261,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-159281
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 522,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 17.96M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-159281
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -119.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -13.27M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001193125-18-159281
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -93.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -14.57M 2018-10-01 2018-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007863
us-gaap NoncashOrPartNoncashAcquisitionInvestmentsAcquired1 Noncash or Part Noncash Acquisition, Investments Acquired USD 1.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0000950170-22-004637
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 4.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap NotesPayable Notes Payable USD 12.73M 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap NotesPayableCurrent Notes Payable, Current USD 7.27M 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OperatingExpenses Operating Expenses USD 97.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -97.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OperatingLeaseCost Operating Lease, Cost USD 331,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 100,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 4.78M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.38M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.39M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OperatingLeasePayments Operating Lease, Payments USD 300,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap OperatingLeasePaymentsUse Operating Lease, Payments, Use USD 586,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.84M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 690,000 2018-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 464,000 2018-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 0 2018-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007863
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 0 2018-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007863
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 226,000 2018-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 464,000 2018-12-31 2019 Q2 10-Q 2019-08-08 0001564590-19-030904
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 400,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007863
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.11 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.13M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 457,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -73,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -4,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-14 0001193125-15-188267
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -73,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -7,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 218,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 13,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap PaymentsForDeposits Payments for Deposits USD 57,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap PaymentsForRestructuring Payments for Restructuring USD 1.74M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 49,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-10 0001193125-17-078784
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 18,000 2020-01-01 2020-03-31 2021 Q1 10-Q 2021-05-10 0001564590-21-026084
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 83.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 158.63M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-14 0001193125-15-291736
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 158,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 500,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 500,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 7.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap PrepaidInsurance Prepaid Insurance USD 95,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 18.00M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-25 0000950170-22-004637
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 5.99M 2012-01-01 2012-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 64.56M 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041090
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 65.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 442,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-10 0001193125-17-078784
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 10,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 110.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 184.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 20.00M 2017-12-29 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 84.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 3,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-05 0001564590-20-008984
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 800,000 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-10 0001193125-17-078784
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 6,284 2023-08-11 2023 Q3 10-Q 2023-11-14 0000950170-23-063517
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -93.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 597,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap RedeemableNoncontrollingInterestEquityCarryingAmount Redeemable Noncontrolling Interest, Equity, Carrying Amount USD 103.80M 2013-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 1.82M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 78.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 456,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap RestructuringAndRelatedCostIncurredCost Restructuring and Related Cost, Incurred Cost USD 10,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employee 20 2019-07-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.63 2019-07-01 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-041090
us-gaap RestructuringCharges Restructuring Charges USD 10,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap RestructuringCosts Restructuring Costs USD 1.40M 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007863
us-gaap RestructuringReserve Restructuring Reserve USD 376,000 2016-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007863
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 981,000 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -528.36M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap Revenues Revenues USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.97 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 300,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 6.23M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 7.37 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 100,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-10 0001193125-17-078784
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 342,121 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 4.98 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 80,090 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004331
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 698,642 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 4.86 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-10 0001193125-17-078784
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOtherIncreasesDecreasesInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Other Increases (Decreases) in Period shares 328,770 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-04 0001564590-21-011003
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 11.65M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.66 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 11.65M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 5.66 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 3.48 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 62.42 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004331
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 3.49 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Other Share Increase (Decrease) in Period, Weighted Average Exercise Price USD/shares 74.8 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-04 0001564590-21-011003
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 16 2014-06-24 2014 Q3 10-Q 2014-11-13 0001193125-14-411306
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 41,000 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 101.47M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 6.28 2013-01-01 2013-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 6.90M 2014-06-24 2014 Q3 10-Q 2014-11-13 0001193125-14-411306
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 4,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 3.05M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-09 0001193125-18-077456
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 14,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 200,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007863
us-gaap SubleaseIncome Sublease Income USD 28,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-07 0001564590-20-022942
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 92,000 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-10 0001193125-17-078784
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 104.59M 2013-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2014-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2014-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2014-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2014-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap TemporaryEquityValueExcludingAdditionalPaidInCapital Temporary Equity, Par Value USD 103.80M 2013-12-31 2014 FY 10-K 2015-03-25 0001193125-15-103624
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462242
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 59.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115878
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 68.82M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266969
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 16.00M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001564590-21-026084
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 68.82M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-05 0001193125-25-266969

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →